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ABSTRACT
Introduction: Endoscopic retrograde cholangiopancreatography (ERCP) has become the gold standard for diagnosis and
treatment of choledocholithiasis. The American Society for Gastrointestinal Endoscopy (ASGE) in 2010 proposed stratifying
patients into 3 risk levels; however, studies have found controversial results about the predictive parameters of these
diagnostic criteria. The objective of this study is to determine the performance of the high-risk predictive criteria of the ASGE
2010 in the diagnosis of choledocholithiasis in a Colombian Caribbean population. Methods: Retrospective cross-sectional
study, which included patients with suspected choledocholithiasis, and who were taken for evaluation by ERCP, meeting the
criteria proposed by the ASGE of high probability. The result obtained was compared with the presence of choledocholithiasis
on ERCP, from which values and 95% confidence intervals were estimated for sensitivity, specificity, positive and negative
predictive value, and positive and negative likelihood ratio. Results: A total of 118 patient data were included in this study. The
median age of the patients was 46 years (IQR= 31; 17- 89); 78% (n= 92) were female. 65.3% (n= 77) were older than 55 years.
The ERCP result was positive in 81.4% (n= 96) of the patients. The presence of an altered liver profile (90%) was found to be
the most sensitive test, clinical cholangitis (86%) the most specific, the presence of duct lithiasis by US (85%) was the test with
the highest positive predictive value, and the presence of duct lithiasis by US (35%) was the test with the highest negative
predictive value. Conclusions: The predictive parameters of the ASGE 2010 criteria for the diagnosis of choledocholithiasis
show variability with respect to the performance proposed in the guidelines.
Key words: Choledocholithiasis; Lithiasis; Diagnostic Techniques and Procedures; Risk Factors. (source: MeSH NLM).

RESUMEN

Introducción: La colangiopancreatografía retrógrada endoscópica (CPRE) se ha convertido en el estándar de oro para el
diagnóstico y tratamiento de la coledocolitiasis. La Sociedad Americana de Endoscopia Gastrointestinal (ASGE) propuso en
2010 estratificar a los pacientes en 3 niveles de riesgo; sin embargo, los estudios han encontrado resultados controvertidos
sobre los parámetros predictivos de estos criterios diagnósticos. El objetivo de este estudio consiste en determinar el
desempeño de los criterios predictivos de alto riesgo de la ASGE 2010 en el diagnóstico de coledocolitiasis en una población
del Caribe colombiano. Métodos: Estudio transversal retrospectivo, en el que se incluyeron pacientes con sospecha de
coledocolitiasis, y que fueron llevados a evaluación por CPRE, cumpliendo los criterios propuestos por la ASGE de alta
probabilidad. El resultado obtenido se comparó con la presencia de coledocolitiasis en la CPRE, a partir de la cual se estimaron
los valores y los intervalos de confianza del 95% para la sensibilidad, la especificidad, el valor predictivo positivo y negativo,
y la razón de probabilidad positiva y negativa. Resultados: En este estudio se incluyeron los datos de 118 pacientes. La edad
media de los pacientes era de 46 años (RIQ= 31; 17- 89); el 78% (n= 92) eran mujeres. El 65,3% (n= 77) eran mayores de 55
años. El resultado de la CPRE fue positivo en el 81,4% (n= 96) de los pacientes. La presencia de un perfil hepático alterado
(90%) resultó ser la prueba más sensible, la colangitis clínica (86%) la más específica, la presencia de litiasis ductal por US
(85%) fue la prueba con mayor valor predictivo positivo, y la presencia de litiasis ductal por US (35%) fue la prueba con mayor
valor predictivo negativo. Conclusión: Los parámetros predictivos de los criterios de la ASGE 2010 para el diagnóstico de
coledocolitiasis muestran variabilidad con respecto al rendimiento propuesto en las guías.
Palabras clave: Coledocolitiasis; Litiasis; Técnicas y Procesos Diagnósticos; Factores de Riesgo (fuente: DeCS BIREME).
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METHODS

The frequency of gallbladder stones increases with
age. An absolute prevalence of 15% is estimated in
the general population(1). Particularly, in adults over
65 years old, it is between 15 and 30% and increases
from 38 to 53% in octogenarians(2-4). The frequency
of this condition in Colombia is not unrelated to
the reported world literature, some studies even
report a higher frequency(5). This disease has a
significant portion of the emergency services
consultation, being immensely important detect
the early appearance of complications associated
with the presence of stones(6). Choledocholithiasis
is one of the complications that generates greater
morbidity in patients with cholelithiasis, since the
interlocking of the stones in the common bile duct
and subsequent obstruction can generate episodes
of pancreatitis, cholangitis, Mirizzi syndrome, among
other complications(4).

Retrospective cross-sectional study, which included
patients with suspected choledocholithiasis, who
were taken for evaluation by means of endoscopic
retrograde cholangiopancreatography, complying
with the criteria proposed by the ASGE of high
probability, during the period from January 2016
to January 2020 at the Hospital Universitario del
Caribe (HUC), Cartagena - Colombia. The inclusion
criterion was defined as all patients over 18 years old
with a high probability of choledocholithiasis, who
underwent ERCP and who underwent two series of
paraclinical tests in a time no longer than 4 weeks.
Exclusion criteria were all patients with incomplete
complementary examinations, biliary stent, biliary
fistula, biliary stricture or injury, chronic liver disease
that alters liver function, failed ERCP, a history
of cholecystectomy and a set of diagnostic tests
performed in the longest time 4 weeks after ERCP.

Endoscopic retrograde cholangiopancreatography
(ERCP) has become the gold standard for diagnosis
and treatment of patients with high suspicion of
choledocholithiasis(7). However, due to its high
cost, the need for expertise to be performed,
and the risk of complications, it should only be
performed in patients in whom there is a high
suspicion of this pathology(8). The American Society
for Gastrointestinal Endoscopy (ASGE) in 2010 9
proposed stratifying patients into 3 risk levels, based
on the suspicion of choledocholithiasis (Table 1),
since it is not feasible to perform ERCP in all patients
9. Some Studies have found controversial results
on the predictive safety of these diagnostic criteria,
which casts doubt on the benefit of applying the
recommendations of this guideline(10-13).

For patients who met the inclusion criteria, data
were collected on: age, date and ERCP result, gender,
pancreatitis diagnosis, first set of paraclinics (alanine
aminotransferase [ALT], aspartate aminotransferase
[AST], alkaline phosphatase [FA], gamma glutamyl
transpeptidase [GGT], amylase, lipase, total bilirubin,
direct bilirubin, indirect bilirubin, diameter of the
common bile duct and presence of dilatation of the
common bile duct, presence of cholangitis, presence
of choledocholithiasis in previous image, second set
of paraclinics, alteration in liver profile in the two sets
of paraclinics, and change in risk stratification.

Studies in Colombian population about the size of
the common bile duct have reported an average of
4.16 mm for patients with gallbladder and 4.88 mm
for cholecystectomized patients(3). The cut-off point
for the size of the diseased common bile duct to be
taken into account according to the ASGE guidelines
is bigger than 6 mm, that is why it would be higher
than observed in the Colombian population.
Considering these anatomical, technical, economic
and epidemiological aspects, the objective of
this study was to validate the performance of the
predictive criteria of the ASGE 2010 for diagnosis
of choledocholithiasis in a high-level hospital
belonging to the Colombian Caribbean region.
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INTRODUCTION

Statistical analysis was performed using the SPSS
version 25 statistical package. Nominal and ordinal
variables were expressed as percentages, while
discrete and continuous variables were expressed as
median and interquartile range (IQR) given that they
did not have a normal distribution. To evaluate the
performance of the criteria, the result obtained was
compared with the presence of choledocholithiasis
in ERCP, from which the values and 95% confidence
intervals (CI9 5%) of sensitivity, specificity, positive
predictive value were estimated. (PPV) and negative
(NPV), positive and negative likelihood ratio (LR) (LR
+ and LR-).
This research work does not present conflicts of
interest, nor is its performance sponsored by entities
or companies that have involvement with the
investigated field. Likewise, participation in the study
is voluntary, previously justifying informed consent
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to all participants. The variables to be measured
imply the use of non-invasive instruments, so the risk
of damage, incidents or adverse events is unlikely.
Therefore, the research respected the Declaration of
Helsinki, and was classified as a minimal risk study
according to resolution 8430 of 1993 of the Ministerio
de Salud de Colombia and was endorsed by the
Comité de Ética de la Universidad de Cartagena.

ORIGINAL PAPER

RESULTS
A total of 118 patient data were included in this
study. The median age of the patients was 46 years
old (IQR 31; 17-89); 78% (n = 92) were women and
the remaining 22% (n = 26) were men. 65.3% (n = 77)
were older than 55 years. At the time of admission,
only 19.5% (n = 23) had a diagnosis of pancreatitis,
while the remaining 89.5% (n = 95) were not
diagnosed with this complication.
In general terms, a total bilirubin between 1.8 and
4 mg / dL was reported in 31.4% (n = 37); while a
total bilirubin greater than 4 mg / dL was present
in 38.1% (n = 45). Regarding the diameter of the
common bile duct, it had a median of 10 mm (6;
3-96); 76.3% (n = 90) had common bile duct dilation;
9.3% (n = 11) had cholangitis, 90.7% (n = 107) had
an altered liver profile, and 83.1% (n = 98) previously
had choledocholithiasis. The population basic
characteristics are summarized in Table 2. Regarding
the type of image in which choledocholithiasis
had been evidenced, 53.4% (n = 63) was in
cholangioresonance and 46.6% (n = 55) was in
ultrasound of the total abdomen. The endoscopic
retrograde collagiopancreatography (ERCP) result
was positive in 81.4% (n = 96) and negative in 18.6%
(n = 22).
When performing the second set of hepatic and
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pancreatic paraclinics an average of 1 week before
surgery, re-staging was performed in 53.4% (n = 63),
finding that AST had a median of 17 (90; 13-700);
the ALT a median of 24.5 (166; 18-1010); the GGT a
median of 159.5 (550; 25-1525); the AF a median of
102 (317; 45-1500); blood amylase a median of 44
(120; 17-6000); serum lipase a median of 36 (174;
23-16000); total bilirubin a median of 0.65 (13; 0.151.9); indirect bilirubin a median of 0.1 (4; 0.1-14.6)
and direct bilirubin a median of 0.4 (1.25; 0.5-49.7).
The presence of choledocholithiasis in the restaged
patients was 81% (n = 51). The differences between
the first and the second set are found in Table 3.
Evaluating the predictive parameters of the 2010
ASGE criteria in the diagnosis of choledocholithiasis,
from the data obtained, it was found that the
presence of an altered liver profile (90%), the
presence of US duct stones (86%) ), and common bile
duct dilation of> 6 mm (79%) were the most sensitive
tests; cholangitis clinic (86%), bilirubin 1.8 to 4 mg /
dl (73%), pancreatitis clinic (68%) and age> 55 years
(68%), were the most specific tests; the presence of
US duct lithiasis (85%), common bile duct dilation> 6
mm (84%) and a bilirubin of 1.8 to 4 mg / dl (84%) were
the tests with the highest positive predictive value;
the presence of US duct lithiasis (35%), common bile
duct dilation> 6 mm (29%) and a bilirubin of 1.8 to 4
mg / dl (20%) were the tests with the highest negative
predictive value; the presence of US duct lithiasis
(1.26%), common bile duct dilation> 6 mm (1.23%)
and a bilirubin of 1.8 to 4 mg / dl (1.19%), were the
tests with the highest positive likelihood; and finally,
the biliary pancreatitis clinic (1.22%), the cholangitis
clinic (1.07%) and a bilirubin> 4 mg / dl (1.05%), were
the tests with the highest negative likelihood. The
summary of the predictive parameters of all the tests
is found in Table 4.
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Table 1. Proposed strategy to assign the risk of choledocholithiasis in patients with symptomatic
cholelithiasis - ASGE 2010(7).

Choledocholithiasis' Magnitude of predictors

Very strong

Predictors
Common bile duct lithiasis on transabdominal ultrasonography
Ascending cholangitis clinic
Bilirubin> 4 mg / dl

Strong

Common bile duct dilated on ultrasonography (> 6
mm with gallbladder in situ)
Bilirubin level between 1.8 - 4 mg / dl
Impaired liver function tests other than bilirubin

Moderate

Age over 55 years
Biliary pancreatitis clinic

ORIGINAL PAPER

A probability of choledocholithiasis is assigned based
on clinical preachers
Presence of some very strong predictor

High*

Presence of both strong predictors

High*

No presence of predictors

Low°

Other patients

Intermediate+

* High risk: Indication of preoperative ERCP or intraoperative cholangiography.
+ Intermediate risk: Indication of additional imaging studies.
° Low risk: Indication of cholecystectomy without additional studies.

Table 2. Basic characteristics of the study population (n = 118).
Parameter

Median - RIQ

Age in years

46 (31; 17-89)

Sex, women (%)

92 (78%)

Over 55 years old, n (%)

77 (65.3%)

Diagnosis of pancreatitis, n (%)

23 (19.5%)

AST

254 (254; 6-1272)

ALT

236.5 (297; 9-1480)

GGT

572 (345; 86-2420)

FA

319 (285; 72-1520)

Amylase

74.5 (118; 15-6625)

Lipase

91.5 (138; 15-41700)

BT

18.5 (41; 0.3-49.8)

BI

6 (12; 0.1-32.7)

BD

16 (29; 0.1-46.4)

Bilirubin between 1.8 and 4 mg / dl, n (%)

37 (31.4%)

Bilirubin higher than 4 mg / dl, n (%)

45 (38.1%)

Common bile duct diameter, mm

10 (6; 3-96)

Common bile duct dilation, n (%)

90 (76.3%)

Cholangitis, n (%)

11 (9.3%)

Altered liver profile, n (%)

107 (90.7%)

Previous choledocholithiasis, n (%)

98 (83.1%)

https://inicib.urp.edu.pe/rfmh/vol21/iss4/13
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Table 3. Differences between the hepatic and pancreatic paraclinical sets.
Parameters

Median - RIQ

ORIGINAL PAPER

Paraclinical initial set
AST

254 (254; 6-1272)

AST

ALT

236.5 (297; 9-1480)

ALT

GGT

572 (345; 86-2420)

GGT

FA

319 (285; 72-1520)

FA

Amylase

74.5 (118; 15-6625)

Amylase

Lipase

91.5 (138; 15-41700)

Lipase

Total Bilirubin

18.5 (41; 0.3-49.8)

Total Bilirubin

Indirect bilirubin

6 (12; 0.1-32.7)

Indirect bilirubin

Bilirubin direct

16 (29; 0.1-46.4)

Bilirubin direct

Table 4. Found values of the predictive parameters of the 2010 ASGE criteria in the diagnosis of
choledocholithiasis.
Predictors

Sensitivity

Specificity

VPP

VPN

LR+

LR-

% ( Confidence interval 95%)
Very strong
Presence of
gallstones in
the bile duct
due to US

86

32

85

35

1.2

0.4

Cholangitis
Clinic

8

86

73

18

0.5

1.0

Bilirubin> 4
mg / dl

38

59

80

18

0.9

1.0

Fuertes
Common bile
duct dilation
> 6 mm

79

36

84

29

1.2

0.5

Bilirubin 1.8
to 4 mg / dl

32

73

84

20

1.1

0.9

Moderate
Altered liver
profile

90

5

80

9

0.9

2

Biliary pancreatitis clinic

17

68

70

16

0.5

1.2

Age over 55
years

35

68

83

19

1.0

0.9

Pág.
Published
by780
INICIB-URP, 2021

5

Revista de la Facultad de Medicina Humana, Vol.
21 [2021], Iss. 4, Art. 13
Validation of the predictive criteria of high risk for choledocholithiasis

Rev. Fac. Med. Hum. 2021;21(4):776-786.

Tabla 5. Summary of studies that evaluated predictive parameters of choledocholithiasis based on the
ASGE guidelines(11,12,13,14,21,22,23).
Authors

Suarez et al.
2016(13)

Parameters used
Sensitivity

Specificity

VPP

VPN

LR+

LR-

Calculation
presence
in US

0.2

0.9

0.7

0.4

2.6

0.8

Cholangitis
Clinic

0.1

0.9

0.7

0.4

2.3

0.8

Bilirubin> 4
mg / dl

0.6

0.4

0.5

0.4

1.1

0.8

0.8

0.3

0.6

0.5

1.2

0.5

Bilirubin 1.8
to 4 mg / dl

0.2

0.7

0.5

0.4

0.9

1.0

Altered liver
profile

0.9

0.0

0.5

0.5

1.0

0.7

Biliary
pancreatitis
clinic

0.2

0.5

0.3

0.3

0.4

1.4

Age over 55
years

0.3

0.7

0.6

0.4

1.4

0.8

Calculation
presence
in US

14.1

97.1

76.9

61.9

-

-

Bilirubin >4
mg/dl

29.6

84.3

56.8

63.2

-

-

Altered liver
profile

17.1

89.7

68.4

45.2

-

-

Biliary
pancreatitis
clinic

55.6

76.3

52.6

78.4

-

-

Common
bile duct
dilation
> 6 mm

https://inicib.urp.edu.pe/rfmh/vol21/iss4/13
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He et al.
2017(22)

Gómez
Hinojosa et
al. 201814

Muñoz W et al

Calculation
presence
in US

44

97

91

73

15.9

0.5

Cholangitis
Clinic

20

84

44

61

1.2

0.9

Bilirubin >4
mg/dl

22

94

69

65

3.5

0.8

75

63

57

79

2.0

0.4

Bilirubin 1.8
to 4 mg / dl

44

80

59

69

2.2

0.7

Altered liver
profile

77

50

50

77

1.5

0.4

Biliary
pancreatitis
clinic

10

85

29

59

0.6

1.0

Age over 55
years

60

54

46

67

1.3

0.7

Calculation
presence
in US

50.3

63.4

69.4

43.7

1.3

0.7

Cholangitis
Clinic

36.6

81.7

76.7

43.9

2.0

0.7

Bilirubin> 4
mg / dl

42.5

40.9

54.2

30.2

0.7

1.4

Common
bile duct
dilation
> 6 mm

90.2

15.1

63.6

48.3

1.0

0.6

Bilirubin 1.8
to 4 mg / dl

34.6

76.3

70.7

41.5

1.4

0.8

Altered liver
profile

92.8

8.6

62.6

42.1

1.0

0.7

Biliary
pancreatitis
clinic

23.5

49.5

43.4

28.2

0.4

1.5

Age over 55
years

39.9

79.6

76.2

44.6

2

0.7

Common
bile duct
dilation
> 6 mm
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Chandran
A et al.
202112

Jacob et al.
202123

21.1

91

86.5

29.8

2.3

0.8

Cholangitis
Clinic

12.3

93.5

83.7

28.2

1.8

0.9

Bilirubin> 4
mg / dl

26.5

77

75.8

27.8

1.1

0.9

Calculation
presence
in US

99.6

61.9

98.2

87.9

-

-

Cholangitis
Clinic

98.9

22.8

88.7

78.0

-

-

Common
bile duct
dilation
> 6 mm

68.5

69.9

44.4

86.3

-

-

Altered liver
profile

38.5

90.2

34.5

91.6

-

-

Biliary
pancreatitis
clinic

55.0

23.1

15.6

66.5

-

-

Age over 55
years

69.4

36.9

30.3

75.3

-

-

Calculation
presence
in US

17

92

-

-

-

-

Bilirubin >4
mg/dl

66

51

-

-

-

-

Common
bile duct
dilation
> 6 mm

40

79

-

-

-

-

Bilirubin 1.8
to 4 mg / dl

48

55

-

-

-

-

Biliary
pancreatitis
clinic

20

53

-

-

-

-

Age over 55
years

17

83

-

-

-

-
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DISCUSSION
Currently, choledocholithiasis represents the
most common cause of obstructive jaundice and
cholangitis(16), with various diagnostic tools with
predictive parameters subject to anatomical and
sociodemographic variables, which implies the
absence of an optimal and personalized approach
to this type of patient. Based on the above, it was
proposed to carry out this study to analyze the
performance of the predictive criteria of the ASGE
2010 in the diagnosis of choledocholithiasis in a
Colombian Caribbean population. In the last two
decades, several studies have been carried out
evaluating the clinical variables associated with the
appearance of choledocholithiasis in patients with
cholelithiasis. Menezes et al(17) in 2000, indicated
how parameters such as age (> 55 years), female
sex, jaundice, cholangitis, AST, ALT, and ultrasound
bile duct dilation could predict the presence of
choledocholithiasis; hand in hand, Sgourakis et
al18 in 2005 stated that total bilirubin, alkaline
phosphatase, AST and ultrasound bile duct dilation
should be used, which served as the basis for the
creation of the ASGE 2010 criteria(7), distributed
between the magnitude of your prediction (very
strong, strong, moderate). However, later studies
were replicated to corroborate the predictive value
of these criteria, finding different performance
rates(19,20). The summary of studies that evaluated
the predictive parameters of choledocholithiasis
based on the ASGE guidelines is found in Table
5(11,12,13,14,21,22,23).
In this study, as reported in the literature,
the presence of bile duct stones by US is the
strongest predictor associated with the diagnosis
of
choledocholithiasis(11,12,13,14,21,22,23).
Although
some studies describe the usefulness of biliary
pancreatitis as a predictor of choledocholithiasis
(11,12,13,14,21,22,23)
, in the present work, no statistically
significant association was found with the diagnosis
of choledocholithiasis. However, this difference has
also been reported(15); probably due to the difference
in the sample size and undescribed pathological
history. Common bile duct dilation> 6 mm is a
subjective variable, since certain characteristics
such as body mass index, the presence of previous
cholecystectomy, or age (since it has been found
that the diameter of the common bile duct increases
1 mm every 10 years from 60 years, causing a slight
dilation in adulthood), influence this predictor(24).
Based on the above, it can be observed how
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other authors have achieved differences between
these predictive values, and have attributed this
divergence to the same causes(11,12,13,14,21,22,23).
However, contrasting with studies that also analyzed
the differences between the 2010 and 2019 ASGE
guidelines, it was found that divergence persists in
terms of the performance of the diagnostic criteria.
Chandran et al(12) carried out a retrospective study
that included 744 American patients with suspected
choledocholithiasis, who underwent ERCP(12).
When contrasting the specificity between the two
guidelines, a notable improvement was noted
(46.5% to 76%; p <0.001), however, there were no
statistically significant changes between the positive
and negative predictive values(12). In contrast, Jacob
et al(23) carried out a cohort study with 267 patients
with suspected choledocholithiasis, observing
that the 2010 ASGE criteria for the diagnosis of
choledocholithiasis had a higher predictive value
(sensitivity: 68% - specificity: 55%) , compared to the
2019 criteria (sensitivity: 37% - specificity: 80%)(23).
Despite the existence of this divergence between the
parameters and obtaining a low performance, Jacob
et al(23) concluded that the 2019 criteria reduce the
use of ERCP for the diagnosis of choledocholithiasis,
a statement that should be supported by better
quality evidence.
Unlike He et al22 who used a sample of 2724 patients
with suspected choledocholithiasis, of which 43%
met high-risk criteria (1171 patients)(22). The authors
obtained a cut-off score, determining that the
high-risk (very strong) criteria have a probability of
diagnosis> 50%(22). When grouping criteria (presence
of abdominal US stone and / or bilirubin levels> 4 mg
/ dl + dilated common bile duct) they found greater
specificity and positive predictive value; factors to
take into account in future studies. Likewise, the
increase in the sample allowed choosing a precise
probabilistic score (> 50%)(22). However, this study
was carried out in a population of Asian origin
(China); variable to consider regarding anatomical
variations. Therefore, different reasons continue to
be found that could explain the variability of the
performance of these criteria; However, most of
the authors conclude that as these criteria have a
performance equal to or greater than 50%, half of
the ERCPs performed are unnecessary(11,13,14,21).
Unlike the contrasted studies, a highlight of
this study is the evaluation of the 2 laboratory
sets 1 month before surgery and a second set
approximately 1 week before surgery, where
biochemical parameters were evaluated, obtaining
9
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This study is part of the few carried out in Latin America
and the Caribbean, which sought to evaluate the
performance of the ASGE criteria in the diagnosis of
choledocholithiasis(14,15,21), which help us to requalify
and know the behavior of choledocholithiasis at
the regional and national. As limitations, in the
first instance, the analyzed population was 118

Authorship contributions: The authors participated
in the genesis of the idea, project design, data
collection and interpretation, analysis of results and
preparation of the manuscript of this research work.
Financing: Self-financed.

patients, it would have been preferred to study a
larger population to obtain greater statistical power.
In the second measure, other variables added by
the linearity of the retrospective study were not
analyzed. Third, no associations were estimated that
would allow determining the risk or protection value
of each variable. However, this study was carried
out to strengthen the lines of research in general
surgery and to corroborate whether the predictive
parameters proposed by the ASGE have the same
performance in all populations, and it could be
determined that, based on what was proposed in
this study, it is not like this.
t is necessary to carry out multicenter prospective
studies which allow the analysis of a considerable
sample, to obtain statistical strength and power, to be
able to make correlations and new estimates. Based
on the results, it is also imperative to be constantly
attentive to the behavior of the criteria vis-à-vis the
natural population served and from the Colombian
Caribbean, to guarantee safety and effectiveness in
the discard, diagnosis and proper management of
choledocholithiasis.

ORIGINAL PAPER

a new re-staging of previously assessed patients.
Of these, Adams et al20 represented the difference
between the predictions of the laboratory sets,
finding little variation between bilirubin> 4 mg / dl
(first set: sensitivity 30.1%, specificity 82.5%, positive
predictive value 55.8% and negative predictive value
60.3% vs second set: sensitivity 22.3%, specificity
85.6%, positive predictive value 52.9% and negative
predictive value 60.3%); in general, among all
the biochemical markers, the variation was not
significant (first set: sensitivity 47.4%, specificity
73.0%, positive predictive value 56.3% and negative
predictive value 65.4% vs second set: sensitivity
46.3%, specificity 75.5% , positive predictive value
57.8% and negative predictive value 65.9%)(20).
Nevertheless, the sample evaluated was small (179
patients) and they were only evaluated in high-risk
patients(20). Similar results were found by Suarez
et al(13), who carried out a retrospective study that
included 174 patients, observing that the variability
between laboratory sets was not significant either
(first set: sensitivity 54.9%, specificity 68.6%, positive
predictive value 54.9% and negative predictive value
68.6% vs second set: sensitivity 56.9%, specificity
67.1%, positive predictive value 56.9% and negative
predictive value 67.1%)(13). However, in this study, the
performance of the second set allowed re-staging in
more than 50% of the patients, so this point should
be evaluated in greater depth.

CONCLUSIONS
The predictive parameters of the high-risk criteria
for choledocholithiasis according to the American
Society for Gastrointestinal Endoscopy, 2010, show
variability respecting the performance stated in
the guideline. There are no significant differences
between performing a first set and a second set of
laboratories for risk restaging. However, this depends
on the general context of the patient and added
factors. It is necessary to develop personalized
criteria adapted to the factors that influence and
alter this performance.
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